Stroke 

Definition

Stroke is a sudden onset of focal or global neurological deficit lasting >24 hours or leading to death, due to a vascular cause.

Evidence of brain, spinal cord, or retinal infarction/hemorrhage due to vascular pathology.

  • 80–85% Ischemic
  • 15–20% Hemorrhagic


 Types of Stroke

Ischemic Stroke (Most common)

  • Thrombosis (atherosclerosis)
  • Embolism (cardioembolic AF most common)
  • Lacunar infarcts (small vessel disease)

 TOAST(Trial of Org 10172 in Acute Stroke Treatment) Classification

Type

Cause

Large artery atherosclerosis

Carotid, MCA

Cardioembolic

AF, MI, valve disease

Small vessel (lacunar)

HTN, DM

Other

Dissection, vasculitis

Undetermined

Cryptogenic


Hemorrhagic Stroke

 Types

  • Intracerebral hemorrhage (ICH)
  • Subarachnoid hemorrhage (SAH)

 Causes

  • HTN (most common ICH)
  • Amyloid angiopathy (elderly)
  • Aneurysm rupture (SAH)
  • AV malformations
  • Anticoagulants


DIFFERENTIATING STROKE TYPES CLINICALLY

Feature

Ischemic Stroke

Hemorrhagic Stroke

Onset

Sudden

Sudden, often during exertion

Headache

Mild/absent

Severe (common)

Vomiting

Rare

Common

Consciousness

Preserved initially

Early impairment

Seizures

Rare

More common

BUT: Clinical differentiation is unreliable Imaging mandatory

 STROKE MIMICS 

Mimic

Clue

Hypoglycemia

Low glucose

Seizure (Todd paralysis)

Post-ictal state

Migraine

Aura

Brain tumor

Progressive symptoms

Conversion disorder

Inconsistent exam


Clinical Features

  • Abrupt onset
  • Focal deficits (not diffuse, unlike metabolic encephalopathy)
  • Negative symptoms predominate (loss of function > positive phenomena)

 NEGATIVE vs POSITIVE SYMPTOMS 

Stroke

Seizure

Negative (loss)

Positive (jerks, aura)

Sudden deficit

Progression

Persistent

Post-ictal recovery


BEFAST CRITERIA (STROKE RECOGNITION TOOL)

Component(any one positive)

Clinical Feature

Localization Clue

B – Balance

Ataxia, difficulty walking, dizziness

Cerebellum / posterior circulation

E – Eyes

Diplopia, vision loss, hemianopia

Occipital lobe / brainstem / Posterior Cerebral Artery

F – Face

Facial droop (UMN type)

Corticobulbar tract / Middle Cerebral Artery

A – Arms

Arm drift, hemiparesis

Middle Cerebral Artery / corticospinal tract

S – Speech

Slurred speech (dysarthria) or aphasia

Dominant hemisphere (usually left MCA)

T – Time

Immediate medical attention required

Reperfusion window (thrombolysis/thrombectomy)



CORE CLINICAL FEATURES 

 A. MOTOR DEFICITS

Hemiparesis / Hemiplegia

  • Most common presentation
  • Contralateral weakness (due to corticospinal tract involvement)
  • Distribution:
    • Face + arm > leg MCA stroke
    • Leg > arm ACA stroke

UMN signs

  • Hyperreflexia
  • Spasticity (late)
  • Babinski positive

Facial weakness

  • UMN facial palsy
    • Lower face affected
    • Forehead spared


 B. SENSORY DEFICITS

  • Contralateral:
    • Loss of pain, temperature, touch
  • Cortical sensory deficits:
    • Astereognosis
    • Agraphesthesia
  • Pure sensory stroke classically thalamic infarct


 C. SPEECH & LANGUAGE (DOMINANT HEMISPHERE)

Aphasia (dominant hemisphere, usually left)

Type

Features

Location

Broca (motor)

Non-fluent, good comprehension

Frontal lobe

Wernicke (sensory)

Fluent, poor comprehension

Temporal lobe

Global

Both impaired

Large MCA

Dysarthria

  • Slurred speech (motor problem, not language)

D. VISUAL DEFICITS

  • Homonymous hemianopia (most common)
  • Quadrantanopia:
    • “Pie in the sky” temporal lobe
    • “Pie on the floor” parietal lobe
  • Cortical blindness bilateral occipital

E. COORDINATION & CEREBELLAR SIGNS

  • Ataxia
  • Dysmetria
  • Intention tremor
  • Nystagmus
  • Vertigo (posterior circulation stroke)

F. CRANIAL NERVE DEFICITS (BRAINSTEM STROKE)

“Crossed findings” 

  • Ipsilateral cranial nerve deficit
  • Contralateral body weakness/sensory loss

Examples

  • Diplopia
  • Dysphagia
  • Dysarthria
  • Facial numbness

 G. COGNITIVE & HIGHER FUNCTION DEFICITS

  • Neglect (non-dominant parietal lobe)
  • Apraxia
  • Agnosia
  • Memory impairment (temporal lobe)


 FEATURES BASED ON VASCULAR TERRITORY 

A. Middle Cerebral Artery (MCA)

7

  • Face + arm weakness > leg
  • Aphasia (dominant)
  • Neglect (non-dominant)
  • Homonymous hemianopia

 B. Anterior Cerebral Artery (ACA)

6

  • Leg > arm weakness
  • Abulia (lack of initiative)
  • Urinary incontinence

C. Posterior Cerebral Artery (PCA)

6

  • Visual field defects
  • Cortical blindness
  • Memory deficits
  • Alexia without agraphia

D. LACUNAR STROKES

  • Pure motor stroke
  • Pure sensory stroke
  • Ataxic hemiparesis
  • Dysarthria–clumsy hand

E. POSTERIOR CIRCULATION STROKE

  • Vertigo
  • Ataxia
  • Diplopia
  • Dysphagia
  • Altered consciousness

WARNING SYMPTOMS (TIA / EVOLVING STROKE)

  • Transient weakness
  • Speech difficulty
  • Amaurosis fugax (monocular vision loss)

RED FLAGS  SUGGESTING HEMORRHAGIC STROKE

  • Severe headache (“thunderclap”)
  • Vomiting
  • Rapid decline in consciousness
  • Seizures

Diagnosis 

 Only 2 tests are truly mandatory and should NOT delay therapy:

  1. NCCT Head
  2. Blood Glucose

Others should not delay thrombolysis unless specific suspicion exists (as per American Heart Association / American Stroke Association)

1. Imaging (First step)

 FIRST-LINE: Non-Contrast CT (NCCT Brain)

  • Exclude hemorrhage (absolute contraindication to thrombolysis)
  • Detect early ischemic changes
  • Assess extent of infarction

NCCT FINDINGS

 Early Ischemic Signs (subtle, within hours)

  • Loss of gray-white differentiation
  • Loss of insular ribbon
  • Obscuration of lentiform nucleus
  • Sulcal effacement

 Hyperdense Artery Sign

  • e.g., Hyperdense MCA sign
  • Indicates large vessel occlusion (LVO)

 2. ASPECTS SCORE 

Used on NCCT to quantify early ischemic changes in MCA territory.

Score

Meaning

Clinical implication

10

Normal

Best candidate

7–10

Small infarct core

Thrombolysis ± thrombectomy

<6

Large infarct core

Poor outcome, relative contraindication

  • ASPECTS ≥6 thrombectomy benefit

3. CT ANGIOGRAPHY (CTA)

  • Detect large vessel occlusion (LVO)
  • Plan thrombectomy

CTA Findings

  • MCA, ICA, basilar artery occlusion
  • Tandem lesions
  • Collateral circulation

 Role:

  • Mandatory before mechanical thrombectomy
  • Should not delay thrombolysis if already eligible

4. CT PERFUSION (CTP)

Differentiates:

  • Infarct core (irreversible)
  • Penumbra (salvageable tissue)

Parameters:

Parameter

Meaning

CBF

Core infarct

CBV

Core infarct

MTT / Tmax

Penumbra

CTP Maps Mismatch Concept: Mismatch

  • Penumbra > Core salvageable brain

Used in:

  • Extended window thrombectomy (6–24 hrs)
  • Trials:
    • DAWN trial
    • DEFUSE 3 trial

5. MRI IN STROKE

Sequence

What it Detects

Key Clinical Use

DWI (Diffusion Weighted Imaging)

Cytotoxic edema (restricted diffusion)

Gold standard for acute ischemia

ADC (Apparent Diffusion Coefficient)

Confirms restriction (low ADC)

Differentiates true vs T2 shine-through

FLAIR

Vasogenic edema

Determines stroke timing

GRE/SWI

Blood products (hemorrhage)

Detects microbleeds, hemorrhage

PWI (Perfusion Weighted Imaging)

Perfusion deficits

Penumbra assessment

MRA (MR Angiography)

Vessel occlusion

Identifies large vessel occlusion


  • DWI positivity
    = earliest sign of infarction
  • Sensitivity: >95% for acute ischemic stroke

 Pathophysiology:

  • Energy failure Na⁺/K⁺ pump failure cytotoxic edema diffusion

 DWI–FLAIR Mismatch (Wake-Up Stroke)

  • DWI positive + FLAIR negative stroke <4.5 hours

Clinical Importance:

  • Basis of WAKE-UP trial
  • Allows IV thrombolysis even when onset unknown

 MRI for Penumbra (Tissue at Risk)

PWI–DWI Mismatch Concept

  • DWI lesion = infarct core
  • PWI deficit > DWI lesion = salvageable penumbra

Clinical Use:

  • Selection for thrombectomy beyond 6 hours
  • Based on trials like:
    • DAWN trial
    • DEFUSE 3 trial
  • MRI (or CT perfusion) used for extended window (6–24 hr) thrombectomy selection

Test

Purpose

ECG (12-lead)

Detect AF, arrhythmias, MI

Cardiac monitoring (telemetry)

Detect paroxysmal AF

CBC (Hb, platelets)

Baseline, exclude thrombocytopenia,Platelets ≥100,000 for thrombolysis

Coagulation profile (PT/INR, aPTT)

Assess bleeding risk,INR ≤1.7 for IV thrombolysis

Renal function (Cr, urea)

Contrast safety (CTA/MRA),Do NOT delay reperfusion for this unless high risk

Electrolytes

Identify metabolic causes,Hyponatremia can mimic stroke

Cardiac enzymes (Troponin)

Detect concurrent ACS

Chest X-ray

Baseline, aspiration risk